Case Study Validation: In P. hawaiensis, Phenanthrene presented a ‘High’ hazard rating (HQ e 10) at maximum concentrations, whereas Naphthalene remained in the ‘Low/Moderate’ range, highlighting the need for compound-specific management.
Procedure: Toxic Unit (TU) Analysis
Rationale: TUs are valuable for assessing the threshold of sublethal effects. Because TUs are additive, this metric is the gold standard for assessing mixture toxicity (e.g., sum of TUs for all contaminants in a sample). TUs quantify the magnitude of sublethal toxic stress under different exposure conditions, enabling a threshold-based assessment of sublethal effects, as advocated in the oil toxicity testing frameworks (Parkerton et al., 2023).
Select Endpoint: Use the EC10 value, which represents the onset of sublethal stress.
TU = \( \frac{\text{Environmental concentration}}{\text{EC}_{10}} \)
Implementation: Calculate TUs for each sex and PAH under: Median concentration, 90th percentile concentration, and Maximum concentration
- TU 3c 0.01: negligible sublethal risk
- 0.01 ≤ TU ≤ 0.1: low but measurable sublethal stress
- TU 3c 1: The environmental concentration is below the threshold for initiating sublethal effects.
- TU 3e 1: The environmental concentration exceeds the 10% effect level, suggesting sublethal physiological stress is likely occurring.
Procedure: Acute Risk Quotient (RQ) Determination
Rationale: The RQ assesses the immediate, acute risk posed by peak pollution events. It is less conservative than the HQ but more indicative of immediate population-level impact.
Select Exposure Scenario: Use the Peak (Maximum) Reported Concentration to model the worst-case event.
Select Endpoint: Use the EC50 (Effective Concentration for 50% of the population).
RQ = \( \frac{\text{Peak environmental concentration}}{\text{EC}_{50}} \)
Interpretation Thresholds
- RQ 3c 0.1: negligible acute risk
- 0.1–0.5: low acute risk
- ≥0.5: significant acute risk (EPA, 2024; Singh et al., 2023).
This sex-specific calculation is essential given observed differences in amphipod PAH sensitivity.
Procedure: Sex-Specific Data Analysis
Rationale: This is the critical analytical step often missed in standard protocols.
1. Segregate Data: Perform calculations for Steps 4, 5, and 6 separately for the Male and Female datasets.
2. Calculate Divergence: Compare the TUs, HQs and RQs between sexes.
3. Validation: In the validation dataset using PAHs, female P. hawaiensis exhibited an RQ of 11.89 for Phenanthrene, compared to 7.29 for males. Implication: A risk assessment based solely on male data (or pooled data) would underestimate the risk to the reproductive female population by nearly 40%.
Data Management 26 Reporting
- Automation: For datasets involving multiple contaminants, it is recommended to use statistical software (R or Python) to automate these calculations to prevent manual error.
- Visualisation: Present data in a comparative table that aligns molecular weight, LogKow, and risk indices to visualise trends (e.g., increasing hydrophobicity correlating with increased risk).
The TU–HQ–RQ workflow described above is intentionally generic and may be applied to a broad range of aquatic toxicants beyond PAHs, provided toxicant-specific properties and toxicological endpoints are accounted for during problem formulation. This tiered, percentile-based exposure strategy and the three-metric hazard characterisation (TUs from sublethal thresholds; HQs from PNECs; RQs from acute benchmarks) align with established international guidance for chemical risk assessment and are therefore appropriate for pesticides, pharmaceuticals, polar organics, metals, and other contaminants subject to routine environmental monitoring.
Practical caveats apply: for ionisable or strongly polar compounds, adjust exposure metrics to account for differing bioavailability and use appropriate effect metrics (e.g. chronic NOEC/EC10 derived from water-column assays or internal dose metrics where available). For metals, incorporate speciation and water chemistry (pH, hardness, dissolved organic carbon) into exposure conversion or apply bioavailability models (e.g. the Biotic Ligand Model) before